Vision Monitor- MonCvONE— 510(k) K212936

Substantially Equivalent

Metrovision

FDA 510(k) clearance K212936 for Vision Monitor- MonCvONE, Substantially Equivalent on 2022-11-21. Applicant: Metrovision.

Clearance details

Applicant: Metrovision
Product code: Code GWE
Advisory panel: Neurology
Date received: 2021-09-15
Decision date: 2022-11-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Perenchies, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.